OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 20-5-12.5

Olmesartan medoxomil Amlodipine and Hydrochlorothiazide
$0.8821per EA

Strength

5; 12.5; 20 mg/1; mg/1; mg/1

NDC

33342024307

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207088

On Market Since

7/18/2025

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines
Increased Diuresis
Thiazide Diuretic
Thiazides

Price History

1W

0.0%

1M

+2.2%

3M

-4.2%

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-4.2%